165 related articles for article (PubMed ID: 34491404)
1. Influence of sarcopenia, clinical data, and 2-[
Anconina R; Ortega C; Metser U; Liu ZA; Suzuki C; McInnis M; Darling GE; Wong R; Taylor K; Yeung J; Chen EX; Swallow CJ; Bajwa J; Jang RW; Elimova E; Veit-Haibach P
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1012-1020. PubMed ID: 34491404
[TBL] [Abstract][Full Text] [Related]
2. Combined 18 F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer.
Anconina R; Ortega C; Metser U; Liu ZA; Elimova E; Allen M; Darling GE; Wong R; Taylor K; Yeung J; Chen EX; Swallow CJ; Jang RW; Veit-Haibach P
Clin Nucl Med; 2022 Aug; 47(8):684-691. PubMed ID: 35543637
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Sarcopenia and Metabolic Parameters of
Hinzpeter R; Mirshahvalad SA; Kulanthaivelu R; Murad V; Ortega C; Metser U; Liu ZA; Elimova E; Wong RKS; Yeung J; Jang RW; Veit-Haibach P
Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36899982
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma.
Ma LX; Taylor K; Espin-Garcia O; Anconina R; Suzuki C; Allen MJ; Honorio M; Bach Y; Allison F; Chen EX; Brar S; Swallow CJ; Yeung J; Darling GE; Wong R; Kalimuthu SN; Jang RW; Veit-Haibach P; Elimova E
Cancer Med; 2021 Jan; 10(1):199-207. PubMed ID: 33295697
[TBL] [Abstract][Full Text] [Related]
5. Implications of Sarcopenia and Glucometabolism Parameters of Muscle Derived From Baseline and End-of-Treatment
Tan X; Sun X; Chen Y; Wang F; Shang Y; Zhang Q; Yuan H; Jiang L
Korean J Radiol; 2024 Mar; 25(3):277-288. PubMed ID: 38413112
[TBL] [Abstract][Full Text] [Related]
6. Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation.
Li Y; Zschaeck S; Lin Q; Chen S; Chen L; Wu H
Radiat Oncol; 2019 Feb; 14(1):35. PubMed ID: 30782182
[TBL] [Abstract][Full Text] [Related]
7. Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.
Lee JW; Son MW; Chung IK; Cho YS; Lee MS; Lee SM
Gastric Cancer; 2020 Mar; 23(2):273-284. PubMed ID: 31485803
[TBL] [Abstract][Full Text] [Related]
8. Opportunistic body composition evaluation in patients with esophageal adenocarcinoma: association of survival with
Zhou C; Foster B; Hagge R; Foster C; Lenchik L; Chaudhari AJ; Boutin RD
Ann Nucl Med; 2020 Mar; 34(3):174-181. PubMed ID: 31823231
[TBL] [Abstract][Full Text] [Related]
9. Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma.
Papaxoinis G; Weaver JMJ; Khoja L; Patrao A; Stamatopoulou S; Alchawaf A; Owen-Holt V; Germetaki T; Kordatou Z; Mansoor W
Acta Oncol; 2017 Sep; 56(9):1224-1232. PubMed ID: 28524708
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
Chang S; Kim SJ
Cancer Biother Radiopharm; 2016 Feb; 31(1):1-6. PubMed ID: 26844846
[TBL] [Abstract][Full Text] [Related]
11. Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection.
Lee JW; Lee MS; Chung IK; Son MW; Cho YS; Lee SM
World J Gastroenterol; 2017 Apr; 23(13):2385-2395. PubMed ID: 28428718
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Lee JW; Na JO; Kang DY; Lee SY; Lee SM
Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
Hofheinz F; Li Y; Steffen IG; Lin Q; Lili C; Hua W; van den Hoff J; Zschaeck S
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816
[TBL] [Abstract][Full Text] [Related]
14. The value of 18F-FDG-PET testing in the management of esophageal and gastroesophageal junction adenocarcinoma - review.
Zemanová M; Obermannová R; Haruštiak T
Klin Onkol; 2021; 34(2):113-119. PubMed ID: 33906359
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer.
Song BI; Kim HW; Won KS; Ryu SW; Sohn SS; Kang YN
Medicine (Baltimore); 2015 Jul; 94(26):e1037. PubMed ID: 26131811
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of [18F]-FDG PET/CT Radiomics Combined with Sarcopenia Status among Patients with Advanced Gastroesophageal Cancer.
Hinzpeter R; Mirshahvalad SA; Kulanthaivelu R; Ortega C; Metser U; Liu ZA; Elimova E; Wong RKS; Yeung J; Jang RW; Veit-Haibach P
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358733
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
Bütof R; Hofheinz F; Zöphel K; Stadelmann T; Schmollack J; Jentsch C; Löck S; Kotzerke J; Baumann M; van den Hoff J
J Nucl Med; 2015 Aug; 56(8):1150-6. PubMed ID: 26089549
[TBL] [Abstract][Full Text] [Related]
19. Texture analysis of
Nakajo M; Jinguji M; Nakabeppu Y; Nakajo M; Higashi R; Fukukura Y; Sasaki K; Uchikado Y; Natsugoe S; Yoshiura T
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
